IRCT138804162109N1已完成4 期
Assessment of Pamidronate effect on bone mineral density of kidney transplant patients in comparison with Alendronate in the first 6 month after transplantation
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 70 years（—）
- 性别
- All
入选标准
- •Kidney transplantation candidates, aged above 20 with low bone mineral density (T-Score < -2) in spine or total femur or femoral neck. Exclusion criteria: Inability to stay in upright position for 30 minute, History of hypersensitivity reaction, Hyperparathyroidism, Hyperthyroidism, Hypocalcemia, Hypercalcemia, GFR < 35 ml/min or creatinine > 3 mg/dL, Active peptic ulcer disease, Jaw avascular necrosis, Uveitis, History of fracture druring 2 years prior to the study, Achalasia, or delayed esophagus emptying
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
The effect of pamidronate treatment on bone health in patients with neuromuscular disease undergoing hip surgery. - Using pamidronate in patients with CP undergoing hip surgery.Children with neuromuscular conditions undergoing hip surgery. Aiming to identify whether pamidronate a licenced medicine mainatins bone mineral density in patients with neuromuscular conditions undergoing hip surgery.EUCTR2009-013777-17-GBCentral Manchester and Manchester University Children's Hospital NHS Trust.12
已完成
4 期
A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.Bone LossNCT00738257Novartis Pharmaceuticals126
已完成
不适用
Effect of pamidronate on bone loss and implant stability after total hip arthroplastyPeriprosthetic bone loss after total hip replacementMusculoskeletal DiseasesPeriprosthetic bone lossISRCTN37786144Arthritis Research Campaign (ARC) (UK)
已完成
不适用
Efficacy of pamidronate for adult osteogenesis imperfecta: uncontrolled study.Osteogenesis imperfectaJPRN-UMIN000031290Kobe University Hospital10
已完成
2 期
Effect of Pamidronate on treatment of bone painsCondition 1: Bone pains in Cancer patients with bone metastases. Condition 2: Hypercalcemia in Cancer patients with bone metastases. Condition 3: Quality of life in Cancer patients with bone metastases.Secondary malignant neoplasm of bone and bone marrowDisorders of calcium metabolismLifestyle-related conditionIRCT2013032212197N5Vice chancellor for research of Tonekabon Islamic Azad University41